Sources | Names Used |
---|---|
CTRPv2 | compound 1B |
PharmacoGx | compound 1B |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MORN4 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | SCOC | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | PARD6B | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | RDX | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | WSCD2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
mRNA | MRPL51 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | LIG3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | DUS4L | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | RP11-195F19.5 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | BRD8 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |